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Introduction: 
Stevens-Johnson syndrome is a rare, serious disorder 
of your skin and mucous membranes. It's usually a 
reaction to a medication or an infection. Often, it 
begins with flu-like symptoms, followed by a painful 
red or purplish rash that spreads and blisters. Then the 
top layer of the affected skin dies, sheds and then 
heals.Stevens-Johnson syndrome is a medical 
emergency that usually requires hospitalization.1 
Treatment focuses on eliminating the underlying 
cause, controlling symptoms and minimizing 
complications as skin regrows. Recovery after Stevens-
Johnson syndrome can take weeks to months, 
depending on the severity of condition. If it was 
caused by a medication, you'll need to permanently 
avoid that drug and others closely related to it.2,3 
 
Case Report  
A 43 year old patient, came to emergency department 
in Benazir Bhutto hospital. Patient was conscious with 
a GCS of 15 by 15 and normal vitals.He complained of 
rash and itching  all over body .On history 
taking,patient told that he went to TB hospital in 
Rawalpindi for TB workup as advised by some doctor 
in Lahore.TB workup came negative  and doctor 
prescribed levofloxacin ,ibuprofen and an expectorant 
for LRTI.He took 1st dose of medications  3 days back 
and  after taking the dose,he started to develop ulcers 
in mouth and lips and genital areas with multiple 
blisters and bullae on legs and arms (Figure 1).Patient 
discontinued the medication .He has no known 
comorbids.He had no other significant medical or 
social history. On examination,patient was afebrile 
with a BP of 120 by 80,pulse 80 per min respiratory 
rate of 16 per min.There were multiple blisters and 
bullae on legs and arms with desquamating lesions on 
lips.There were ulcers in mouth and genital areas.Rest 
of systemic examination was  unremarkable. 
Patient was retained in ER and IV line was maintained 
and was given injection Avil and Solcortif 
250mg,injection calamox ,injection ceftriaxone and 
injection zantac.Subsequently, patient was shifted to 
medical unit II of BBH for diagnosis and further 
management.In ward ,blood tests were taken and were 
found within normal limits. Dermatology consultation 
was taken and patient diagnosed of Steven Johnson 
Syndrome on basis of history and skin lesions and skin 
biopsy which showed less than 10  percent 
involvement of skin. Treatment given to patient was 
tablet deltacortil (5mg)  4+4; Kenalog 
Orabase(triamcinolone acetonide) BD on affected 
areas; Daktarin oral gel (Miconazole) BD on affected 
areas; Paraffin Guazes BD on affected areas; Inj 
calamox (Coamoxiclav) 1.2 g XTDS; Hydrex Emollient 
.Addition of unnecessary medications to treatment 
plan was prohibited.Patient remained on these 
medications for a week in ward and his condition 
improved.He was advised not to take these 
medications in future and discharged after a week 
since his admission.He was followed up in OPD and 
his condition further improved. 
 
 
Figure 1: Steven Johnson Syndrome – Ulcers on lips and 
oral cavity 
 
Discussion 
Steven Johnson Syndrome (SJS) is a rare condition, 
with a reported incidence of around 2.6 to 6.1 cases per 
million people per year. The condition is more 
common in adults than in children.5 Women are 
affected more often than men.SJS usually begins with 
fever, sore throat, and fatigue, which is commonly 
misdiagnosed and therefore treated with antibiotics. 
Ulcers and other lesions begin to appear in the mucous 
membranes, almost always in the mouth and lips, but 
also in the genital and anal regions. Those in the 
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mouth are usually extremely painful and reduce the 
patient's ability to eat or drink occurring at a two to 
one ratio.6 
SJS is thought to arise from a disorder of the immune 
system.The immune reaction can be triggered by 
drugs or infections. Genetic factors are associated with 
a predisposition to SJS.7SJS may be caused by adverse 
effects of the drugs vancomycin, allopurinol, 
valproate, levofloxacin, diclofenac, etravirine, 
isotretinoin, fluconazole,valdecoxib, sitagliptin, 
oseltamivir, penicillins, barbiturates, sulfonamides, 
phenytoin, azithromycin, oxcarbazepine, zonisamide, 
modafinil, lamotrigine, nevirapine, pyrimethamine, 
ibuprofen, ethosuximide, carbamazepine, bupropion, 
telaprevir, and nystatin.8 
The second most common cause of SJS  is infection, 
particularly in children. This includes upper 
respiratory infections, otitis media, pharyngitis, and 
Epstein-Barr virus, Mycoplasma pneumoniae and 
Cytomegalovirus infection.9 Diagnosis is based on less 
than 10 percent involvement of skin. If it is more than 
30 percent it is toxic epidermal necrolysis.SJS 
constitutes a dermatologic emergency.Treatment 
consists of supportive care and corticosteroids.10 
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